Home / Healthcare / Global Industry Insight: Drug of Abuse Testing Market Development and Demand Forecast to 2020

Global Industry Insight: Drug of Abuse Testing Market Development and Demand Forecast to 2020

Published: May 2015 | No Of Pages: 74 | Published By: P & S Market Research

Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they're not a diagnostic test for addiction. These tests may be used for monitoring treatment. The testing technologies consist of immunoassay technique and chromatography technique, used for both onsite as well as laboratory testing.

Key findings of Drug of Abuse Testing Market:

  • The global drug of abuse testing market is expected to reach $3.9 billion in 2020, mainly driven by increased use of illicit drugs and need of drug abuse testing at organizational level.
  • Onsite testing market is more than double the size of laboratory testing market due to ease of use, cost effectiveness and immediate results.
  • Urine followed by saliva is the most common specimen used in the drug of abuse testing. Hair, as a specimen, is also becoming a more effective way for testing long term drug use.
  • North America was the largest market by geography for drug abuse testing in 2014, with 76.4% share of the total market. It was followed by Europe with 16.4% share and Asia with a 4.7% share of the total market.

The use of illicit drugs is rising every year globally and has become a big concern for countries including the U.S., the U.K. Japan, Germany, India and China. Illicit drugs in use include heroin, cannabis, cocaine, ecstasy and amphetamine. With a rapid increase in drug trafficking, the need for drugs for abuse testing has been on rise. There are several factors driving the drug of abuse testing market, such as increased drug testing needs at the organizational level, a global rise in the use of illegal drugs and increase in the consumption of illicit drugs.

On the other hand, the drug of abuse testing market is impacted by social concerns attached with workplace drug testing and legalization of various illicit drugs. In November 2012, Colorado and Washington State legalized possession of small amounts of marijuana for private recreational use.

According to data from the UNODC and European crime-fighting agency Europol, the annual global drugs trade is worth around $435.0 billion a year, with the annual cocaine trade worth $84 billion.

On the basis of type of tests, the market is divided into laboratory testing and onsite testing. Laboratory based tests requires skilled and trained personnel for providing detailed analysis. Whereas, onsite drugs of abuse testing provide immediate results. And on the basis of sample used for testing, urine is the preferred sample type. Hair, oral fluid and sweat are the other preferred samples used for drugs of abuse testing.

Major Competitors: Roche Holding Limited, Quest Diagnostics, Laboratory Corporation of America Holdings, Alere, Inc., Abbott Laboratories, Randox laboratories, Psychemedics Corporation, Bio-Rad Laboratories, Sonic Healthcare and Thermo Fisher Scientific are the major players in the global drug of abuse testing market.

Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
  • Uncovers potential demands in the market
  • Porter analysis identifies competitive forces within the market
  • Provides information on the historical and current market size and the future potential of the market
  • Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable)
  • Highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments and merger & acquisitions
  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics.
  • Profiles provide better understanding of competition as well as the demands of the market.

Scope of Report

The research offers Drug of Abuse Testing market size and market forecast for the period 2011 to 2020. The market is breakdown as follows:

GLOBAL MARKET BREAKDOWN

  • By type of test – includes global market size of onsite and laboratory testing.
  • By type of sample – includes global market size of urine, hair saliva and others.
  • By geography – includes market size of North America, Europe, Asia-Pacific and others.

GLOBAL MARKET BREAKDOWN BY TYPE OF TESTS

  • North America – includes market breakdown by type of tests in North America and in the U.S.
  • Europe – includes market breakdown by type of tests in Europe and countries including the U.K., France and Germany.
  • Asia-Pacific – includes market breakdown by type of tests in Asia-Pacific and countries including China, Japan and India.

GLOBAL MARKET BREAKDOWN BY TYPE OF SAMPLE

  • Includes global market size breakdown by type of sample.

GLOBAL MARKET BREAKDOWN BY GEOGRAPHY

  • North America – includes market size of the U.S. and rest of North America.
  • Europe – includes market size of the U.K., France, Germany and rest of Europe.
  • Asia-Pacific - includes market size of China, Japan, India and rest of Asia-Pacific.

REASON TO BUY?

  • Develop strategies for market entry and expansion by identifying the segments that ensure growth
  • Avail tailored research service of 15 hours with the report (without paying any extra cost) for your any specific requirement unmet in the report.
  • Gain an overview of the current market situation, historic development, current trends and future outlook of the market in various regions
  • Identify new and different windows of opportunity to cover loopholes in the product portfolio and align them as per the markets with a greater growth potential
  • Frame informed and customized strategies for each region depending on constraints, trends and patterns of the market in each country
  • Create competitive counter- strategies, from data that tracks and analyzes the trends of companies entering and leaving the market
  • Evolve effective strategies for marketing as well as production by ascertaining market categories that offer maximum opportunities for consolidations, strategic partnerships and investments
  • Identify market players with potentially strong product portfolio for acquisitions or mergers

Chapter 1.   Research Scope & Methodology

1.1          Market Definition

1.2          Market Scope

   1.2.1       Market Breakdown by Type of Test

   1.2.2       Market Breakdown by Sample

   1.2.3       Market Breakdown by Geography

1.3          Research Methodology and Sources

Chapter 2.   Executive Summary

2.1          Key Findings

2.2          Research Summary

Chapter 3.   Market Outlook

3.1          Introduction

  3.1.1      International Drug Trafficking

  3.1.2      Drug trafficking and illicit drug use in North America

  3.1.3      Drug trafficking and illicit drug use in Europe

  3.1.4      Drug trafficking and illicit drug use in Asia-Pacific

3.2          Technology Analysis – Drug Abuse Testing Market

  3.2.1      Chromatography technology

  3.2.2      Immunoassay technology

3.3          Single vis-à-vis Multiple Parameter Test

3.4          Factors Driving the Market and its Impact on Market Forecast

  3.4.1      Increased use of drug testing at organizational level

  3.4.2      Increased production and trade of illicit drugs worldwide

  3.4.3      Global increase in road accidents and death rates

  3.4.4      Increase in the consumption of illegal drugs

  3.4.5      Impact analysis of drivers on market forecast

3.5          Factors Hindering the Market and its Impact on Market Forecast

  3.5.1      Legalization of drugs

  3.5.2      Social issues associated with drug abuse testing

  3.5.3      Inability of testing products to detect low-dose designer drugs

  3.5.4      Impact analysis of restraints on market forecast

Chapter 4.   Global Market Size & Forecast (2011-2020)

4.1          Global Market Breakdown by Type of Test

4.2          Global Market Breakdown by Sample

4.3          Global Market Breakdown by Region

Chapter 5.   Global Market Breakdown by Type of Test

5.1          Onsite Testing

5.2          Laboratory Testing

5.3          North America Market by Type of Test

  5.3.1      U.S. drugs of abuse market by type of test

5.4          Europe Market by Type of Test

  5.4.1      The U.K. drugs of abuse market by type of test

  5.4.2      Germany drugs of abuse market by type of test

  5.4.3      France drugs of abuse market by type of test

5.5          Asia-Pacific Market by Type of Test

  5.5.1      India drugs of abuse market by type of test

  5.5.2      China drugs of abuse market by type of test

  5.5.3      Japan drugs of abuse market by type of test

Chapter 6.   Global Market Breakdown by Sample

Chapter 7.   Global Market Breakdown by Region

7.1          North America Market Breakdown by Country

  7.1.1      Drug abuse market scenario in the U.S.

7.2          Europe Market Breakdown by Country

  7.2.1      Drug abuse market scenario in the U.K.

  7.2.2      Drug abuse market scenario in France

  7.2.3      Drug abuse market scenario in Germany

7.3          Asia-Pacific Market Breakdown by Country

  7.3.1      Drug abuse market scenario in India

  7.3.2      Drug abuse market scenario in China

  7.3.3      Drug abuse market scenario in Japan

Chapter 8.   Competitive Analysis

8.1         Porter's Five Forces of Competitive Position Analysis

  8.1.1      Bargaining power of buyers

  8.1.2      Bargaining power of suppliers

  8.1.3      Threat of new entrants

  8.1.4      Intensity of rivalry

  8.1.5      Threat of substitutes

Chapter 9. Company Profiles

9.1          Roche Holding Limited

  9.1.1      Business Overview

  9.1.2      Products and Services

  9.1.3      Recent Developments

9.2          Quest Diagnostics

  9.2.1      Business Overview

  9.2.2      Products and Services

  9.2.3      Recent Developments

9.3          Laboratory Corporation of America Holdings

  9.3.1      Business Overview

  9.3.2      Products and Services

  9.3.3      Recent Developments

9.4          Alere Inc.

  9.4.1      Business Overview

  9.4.2      Products and Services

  9.4.3      Recent Developments

9.5          Abbott Laboratories

  9.5.1      Business Overview

  9.5.2      Products and Services

  9.5.3      Recent Developments

9.6          Randox Laboratories Ltd

  9.6.1      Business Overview

  9.6.2      Products and Services

  9.6.3      Recent Developments

9.7          Psychemedics Corporation

  9.7.1      Business Overview

  9.7.2      Products and Services

  9.7.3      Recent Developments

9.8          Bio-Rad Laboratories, Inc.

  9.8.1     Business Overview

  9.8.2      Products and Services

  9.8.3      Recent Developments

9.9          Sonic Healthcare

  9.9.1      Business Overview

  9.9.2      Products and Services

  9.9.3      Recent Developments

9.10        Thermo Fisher Scientific Inc.

  9.10.1    Business Overview

  9.10.2    Products and Services

  9.10.3    Recent Developments

Chapter 10.         Appendix

10.1        List of Abbreviations

TABLE 1     SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2     GLOBAL DRUG ABUSE TESTING MARKET SNAPSHOT (2015 AND 2020)

TABLE 3     WORLDWIDE NUMBER OF ILLICIT DRUG USERS, BY MAJOR DRUGS, % SHARE (2011)

TABLE 4     MULTIPLE PARAMETER TEST ADVANTAGES OVER SINGLE PARAMETER TEST

TABLE 5     DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6     RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 7     GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 8     GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 9     GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2011 – 2014)

TABLE 10     GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2015 – 2020)

TABLE 11     GLOBAL MARKET BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 12     GLOBAL MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 13     ONSITE SCREENING TEST – ADVANTAGES AND DISADVANTAGES

TABLE 14     LABORATORY DRUG TEST - ADVANTAGES AND DISADVANTAGES

TABLE 15     NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 16     NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 17     U.S. MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 18     U.S. MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 19     EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 20     EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 21     THE U.K. MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 22     THE U.K. MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 23     GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 24     GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 25     FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 26     FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 27     ASIA-PACIFIC MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 28     ASIA-PACIFIC MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 29     INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 30     INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 31     CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 32     CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 33     JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 34     JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 35     SAMPLE ANALYSIS – ADVANTAGES AND DISADVANTAGES

TABLE 36     NORTH AMERICA MARKET BREAKDOWN BY COUNTRY, $M (2011 – 2014)

TABLE 37     NORTH AMERICA MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 38     EUROPE MARKET BREAKDOWN BY COUNTRY, $M (2011 – 2014)

TABLE 39     EUROPE MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 40     ASIA-PACIFIC MARKET BREAKDOWN BY COUNTRY, $M (2011 – 2014)

TABLE 41     ASIA-PACIFIC MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 42     ROCHE HOLDINGS – KEY FACTS

TABLE 43     QUEST DIAGNOSTICS – KEY FACTS

TABLE 44     LABORATORY CORPORATION OF AMERICA HOLDINGS – KEY FACTS

TABLE 45     ALERE INC. – KEY FACTS

TABLE 46     ABBOTT LABORATORIES – KEY FACTS

TABLE 47     RANDOX LABORATORIES – KEY FACTS

TABLE 48     PSYCHEMEDICS CORPORATION – KEY FACTS

TABLE 49     BIO-RAD LABORATORIES – KEY FACTS

TABLE 50     SONIC HEALTHCARE – KEY FACTS

TABLE 51     THERMO FISHER SCIENTIFIC INC.– KEY FACTS

FIG 1    MARKET SCOPE FOR GLOBAL DRUG ABUSE TESTING MARKET

FIG 2    RESEARCH METHODOLOGY FOR GLOBAL DRUG ABUSE TESTING MARKET

FIG 3    GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2014)

FIG 4    GLOBAL DRUG ABUSE TESTING MARKET SHARE BY SAMPLE (2014)

FIG 5    GLOBAL DRUG ABUSE TESTING MARKET SHARE BY REGION (2014)

FIG 6    GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015)

FIG 7    NORTH AMERICA DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015)

FIG 8    EUROPE DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015)

FIG 9    ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015)

FIG 10   GLOBAL DRUG ABUSE TESTING MARKET SHARE, BY SAMPLE (2015)

FIG 11    NORTH AMERICA DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014)

FIG 12   EUROPE DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014)

FIG 13   ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014)

FIG 14   PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +